Últimas noticias sobre Expensify (NASDAQ:EXFY) Bolsa

Expensify

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay, and travel booking in one app.

Expensify Inc

News

Trading Ideas

GOOGL

LBRDA

RIVN

Soros Fund Management 13F Shows Decreased Stake In Rivian Automotive Convertible Notes By 21% To $155.9M In Principal; Decreased Stake In Wayfair Convertible Notes By 11% To $119.5M In Principal; Decreased Stake In Liberty Broadband Corp By 19% To 1,119,893 Shares; Decreased Stake In Alphabet Class A By 43% To 517,890 Shares; Decreased Put Position In Ishares IBoxx High Yield Corporate Bond ETF By 40% To 1,500,000 Shares

Discover Financial Reports $100.7B In Credit Card Loans As Of October 2024, Up From $98.7B YoY; Average Balances Remain Stable At $100.2B; Net Principal Charge-Off Rate Drops To 4.31% With Disaster Relief Impact, Though Up From 4.42% YoY; Delinquency Rate Rises Slightly To 3.87%

Management

Zillow Group Appoints Jun Choo As COO

Offerings

GYRE

Gyre Therapeutics Files For Up To $150M Mixed Shelf

WIIM

IZEA

IZEA Worldwide shares are trading lower after the company reported worse-than-expected Q3 financial results.

BIO-key Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKYI#NASDAQ">BKYI</a>) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.58) by 32.76 percent.

Earnings

Earnings Beats

BKYI

BIO-key Intl Q3 2024 Adj EPS $(0.39) Beats $(0.58) Estimate

TFFP

TFF Pharmaceutical shares are trading lower after the company announced it will wind down its operations.

Enveric Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENVB#NASDAQ">ENVB</a>) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.52) by 53.85 percent.

ENVB

Enveric Biosciences Q3 2024 GAAP EPS $(0.24) Beats $(0.52) Estimate

AKYA

Akoya Biosciences shares are trading lower after the company reported worse-than-expected Q3 financial results.

DOCN

OKTA

Soros Fund Management 13F Shows Increased Put Position In SPDR S&P 500 ETF By 608% To 2,123,000 Shares; Increased Stake In Ishares Financial Select Sector SPDR ETF By 22,720% To 2,800,000 Shares; Increased Stake In JD.com By 114% To 2,730,000 Shares; Increased Stake In Okta Convertible Notes By 75% To $79.1M In Principal; Increased Stake In DigitalOcean Convertible Notes By 302% To $116.5M In Principal

Buybacks

Primerica Board Authorizes $450M Share Repurchase Program To Occur Through December 31, 2025

XPON

Expion360 shares are trading lower after the company reported a year-over-year decline in Q3 revenue results.

Asset Sales

BLFS

BioLife Solutions Sells Subsidiary, Arctic Solutions, For $6.1M

BENF

Beneficient Q2 2025 Revenue $8.6M Vs $(42.8M) YoY

Chardan Capital analyst Keay Nakae maintains Silence Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLN#NASDAQ">SLN</a>) with a Buy and maintains $55 price target.

Price Target

Analyst Ratings

Chardan Capital Maintains Buy on Silence Therapeutics, Maintains $55 Price Target

DBGI

DBGIW

Digital Brands Group shares are trading lower after the company reported worse-than-expected Q3 EPS results and a year-over-year decline in Q3 revenue.

As the U.S. prepares for what could be a defining legislative session for digital assets, expectations are mounting around potential <a href="https://www.benzinga.com/topic/crypto-regulations">shifts in crypto regulation</a>. 
Robert Leshner, CEO and co-founder of Superstate sees this as a turning point, with Congress possibly advancing long-awaited laws to provide clarity in the industry. 
Speaking ahead of the <a href="https://benzinga.swoogo.com/digital-assets/6342807">Benzinga Future of Digital Assets event</a>, Leshner shared his outlook on what might come next.
See Also: <a href="https://www.benzinga.com/economics/macro-economic-events/24/11/41984825/trump-rally-fades-as-investors-await-powells-remarks-bitcoin-drops-below-90000-whats-driving-markets-thursday">Trump Rally Fades As Investors Await Powell&#8217;s Remarks, Bitcoin Drops Below $90,000: What&#8217;s Driving Markets Thursday?</a>
<h3 class="wp-block-heading">A New Framework for Digital Assets</h3>
With the prospect of a Congress more favorable to digital assets, Leshner anticipates that lawmakers will focus on three core areas: a framework for stablecoins, structured definitions for digital assets, and repealing the SEC's SAB-121 guidance on crypto custody. 
He pointed out the impact of these potential regulations, explaining that they could finally end a "decade of legal grays" and replace it with "black and white rules" that would allow the industry to expand within a clear legal structure.
<figure class="wp-block-image size-full"><a href="https://benzinga.swoogo.com/digital-assets/6342807"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/13235418/905735A6-57D3-4874-9AA1-75D037842DB3-1-13.gif" alt="" class="wp-image-646877" /></a></figure>
<h3 class="wp-block-heading">Addressing Stablecoins and Custody Rules</h3>
One priority on the legislative horizon is a stablecoin bill that would establish guidelines for stablecoins in the U.S. The proposed law aims to clarify the issuance and management of stablecoins, which have become widely used in digital transactions. 
Leshner also emphasized the potential impact of repealing the SEC's SAB-121 guidance, which has restricted crypto custody by placing complex accounting requirements on crypto-related firms. Removing these restrictions, he believes, would open new possibilities for digital asset custody services in the U.S.
<h3 class="wp-block-heading">Defining Crypto Assets</h3>
Leshner highlighted the importance of clear definitions for digital assets, noting that confusion around terminology has long been a barrier for the industry. Proposed measures such as FIT21 aim to categorize digital assets, creating a structured approach that could aid mainstream adoption. Leshner views these definitions as essential for aligning crypto with existing financial regulations, creating a foundation for the industry to grow.
As Leshner prepares to speak at the <a href="https://benzinga.swoogo.com/digital-assets/6342807">Benzinga Future of Digital Assets</a> event, his perspective offers insight into how upcoming legislation could reshape the future of digital finance in the U.S.
<hr class="wp-block-separator has-alpha-channel-opacity" />
As the digital asset market continues to mature, the convergence of regulatory shifts, M&amp;A activities, and adoption trends will define the future of this dynamic field.&nbsp;<a href="https://www.benzinga.com/digital-assets" target="_blank" rel="noreferrer noopener">Benzinga's Future of Digital Assets</a>&nbsp;event in New York City this November will provide industry leaders and investors with a platform to explore these developments further, offering insights into the evolving regulatory environment and the latest market dynamics.
Image via Unsplash

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Events

Exclusives

Interview

Could New Legislation Finally Bring Clarity To US Crypto Rules? Industry Expert Weighs In

MCHP

Soros Fund Management 13F Shows Added Put Position In SPDR S&P 500 ETF With 2,123,000 Shares; Added Stake In Smurfit Westrock With 6,896,971 Shares; Added Put Position In Ishares Russell 2000 ETF With 800,000 Shares; Added Stake In Microchip Technology Convertible Notes With $130.3M In Principal;  Added Stake In Liberty Broadband Corp With 1,119,893 Shares; Added Stake In AstraZeneca With 2,652,771 Shares

SPAI

Safe Pro Group Q3 Revenue $330.756K Up From $163.547K YoY

IPower shares are trading lower after the company reported worse-than-expected Q1 financial results.

Expensify: Staying Bullish On Good Performance And Favorable Prospects

Expensify clears all debt

In a report released today, Eric Martinuzzi from Lake Street maintained a Buy rating on Expensify (EXFY – Research Report), with a price target of ...

Lake Street Sticks to Their Buy Rating for Expensify (EXFY)

Expensify ( ($EXFY) ) just unveiled an announcement. Expensify's Q3 2024 results reveal a promising financial trajectory with a 48% increase in int...

Expensify's Q3 2024 Shows Strong Financial Growth

JMP Securities analyst Aaron Kimson maintained a Buy rating on Expensify (EXFY – Research Report) today and set a price target of $3.25. The compan...

JMP Securities Keeps Their Buy Rating on Expensify (EXFY)

Expensify GAAP EPS of -$0.02, revenue of $35.4M

JMP Securities raised the firm's price target on Expensify (EXFY) to $3.25 from $2.50 and keeps a Market Perform rating on the shares after "mostly...

Expensify price target raised to $3.25 from $2.50 at JMP Securities

Expensify, Inc. (EXFY) Q3 2024 Earnings Call Transcript

Meeting to be held in the Midwest on November '14 hosted by JMP Securities. Published first on TheFly – the ultimate source for real-time, market-m...

Expensify management to meet with JMP Securitiess

The Jury's Still Out On Expensify's Platform 2.0 Approach

EXFY

Press Releases

Expensify Targets Global Self-Employed Market With New Expense Tracking Features

Expensify to Launch New Travel Offering

Expensify Announces Q1 2024 Results

Expensify Unveils Unlimited Virtual Cards for Enhanced Spend Management

Legal

EXPENSIFY ALERT: Bragar Eagel & Squire, P.C. is Investigating Expensify, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Comments

Expensify

Noticias

Últimas noticias sobre Expensify (NASDAQ:EXFY) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL